Network members
You are here
Re-Evaluation of Systemic Early Neuromuscular Blockade and TransThoracic Ultrasound Assessment of the Diaphragm (ROSETTA)
Status:
Stopped
Period:
April 2021
Diaphragm thickness will be measured using ultrasound in a subset of ROSE patients to determine whether the rate and magnitude of decreases in diaphragm thickness are greater in patients receiving neuromuscular blocking agents as compared to the control group.